By combining artificial intelligence with automated robotics and synthetic biology, researchers at the University of Illinois ...

NFL super-agent Leigh Steinberg opens up about the brain trauma crisis in football and his mission to protect athletes ...

Vor Bio is licensing global rights a fusion protein that inhibits two targets to potentially treat the neuromuscular disorder ...

Vor Bio receives ex-Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global Phase 3 development for generalized myasthenia gravis ...

Such detection speed is the result of combining ML and UV absorbance spectroscopy to detect microbial contamination in cell therapy products.

In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant ...

Learn how first-line antiepileptic drugs, personalized care, and lifestyle changes work together to manage generalized ...

Biologics revolutionize generalized myasthenia gravis care with fast-acting, patient-friendly therapies and a robust global pipeline redefining outcomes. The gMG treatment era is shifting rapidly-from ...

Surgeons from the University of Arkansas for Medical Sciences (UAMS) have performed the first transplantation in Arkansas of ...

Basal cell carcinoma is the most common type of cancer. If you’ve been diagnosed with basal cell carcinoma (BCC), you have plenty of company. Basal cell carcinoma is the most common type of skin ...